$KZIA @KaziaTx ICYMI Should be 3 sell side initiations
on Kazia - imminently- The 3 banks who placed deal 3 weeks ago at $15.50 Leerink, Guggenheim, Needham
$KZIA @KaziaTx Research note just in from BTIG:
Kazia Therapeutics Limited (KZIA, Buy 40.00): Evaluation in Rare Epilepsies To Further Validate Pax's Broad CNS Utility $IBB $XBI
$KZIA Nice win this morning ๐ฅ
Partner Sovargen just dosed the first patient with paxalisib in rare, treatment-resistant epilepsies. Kazia gets $2M cash, with up to $17M more in milestones plus royalties on the table
Zero approved drugs for FCD type 2 today, so real unmet need. And Kazia doesn't spend a dime, Sovargen funds it
Same molecule, more shots on goal, all while the TNBC story keeps building
Long $KZIA, not advice
https://t.co/2MySsaH5fd